Endo (NDOI) Inventories, Finished Goods : $159 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Inventories, Finished Goods?

Endo's quarterly finished goods increased from Apr. 2024 ($0 Mil) to Sep. 2024 ($236 Mil) but then declined from Sep. 2024 ($236 Mil) to Dec. 2024 ($159 Mil).

Endo's annual finished goods increased from Dec. 2022 ($0 Mil) to Dec. 2023 ($113 Mil) and increased from Dec. 2023 ($113 Mil) to Dec. 2024 ($159 Mil).

Endo Inventories, Finished Goods Historical Data

The historical data trend for Endo's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Inventories, Finished Goods Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Inventories, Finished Goods

112.85

158.66

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Inventories, Finished Goods	Get a 7-Day Free Trial			-	112.85	-	236.13	158.66

Endo Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.